Merrimack Pharma (NASDAQ: MACK) announced data from multiple presentations at the 26th EORTC-NCI-AACR Symposium on Molecular Targets and Therapeutics. Data ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE